Prostatis Group’s Target TGT Stock Holding History

Prostatis Group’s Portfolio TGT Stock Details TGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-59,751	Closed	-$59.8K	–	225
2023 Q2	$59.8K	Buy	+59,751	New	+$8.87M	0.03%	164

Other funds holding TGT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prostatis Group's TGT Position: Q3 2023 in Review

Prostatis Group sold out of Target (TGT) in Q3 2023, closing a stake of 59,751 shares — an estimated $59.8K sold.

Prostatis Group first reported a position in TGT in Q2 2023 and held it in 1 quarter. The position peaked at $59.8K in Q2 2023. 1,741 funds tracked by Wall St. Rank hold TGT as of Q3 2023.

Prostatis Group reported no remaining Target position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 59,751 Target shares in Q3 2023, an estimated $59.8K.
Prostatis Group first reported a position in Target in Q2 2023 and held it in 1 quarter.
Prostatis Group's Target position peaked at $59.8K in Q2 2023.
1,741 funds tracked by Wall St. Rank held Target as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.